ACUTE CELLULAR REJECTION AND ANTIBODY-MEDIATED REJECTION

KEY REFERENCES

Papers

  1. Billingham ME, Cary NR, Hammond ME, Kemnitz J, Marboe C, McCallister HA, Snovar DC, Winters GL, Zerbe A. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant 1990; 9: 587-93.
  1. Stewart S, Winters GL, Fishbein MC, Tazelaar HD, Kobashigawa J, Abrams J, Andersen CB, Angelini A, Berry GJ, Burke MM, et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 2005; 24: 1710-20.
  1. Angelini A, Andersen CB, Bartoloni G, Black F, Bishop P, Doran H, Fedrigo M, Fries JW, Goddard M, Goebel H, et al. A web-based pilot study of inter-pathologist reproducibility using the ISHLT 2004 working formulation for biopsy diagnosis of cardiac allograft rejection: the European experience. J Heart Lung Transplant 2011; 30: 1214-20.
  1. Kobashigawa J, Crespo-Leiro MG, Ensminger SM, Reichenspurner H, Angelini A, Berry G, Burke M, Czer L, Hiemann N, Kfoury AG, et al. Report from a consensus conference on antibody-mediated rejection in heart transplantation. J Heart Lung Transplant 2011; 30: 252-69.
  1. Berry GJ, Angelini A, Burke MM, Bruneval P, Fishbein MC, Hammond E, Miller D, Neil D, Revelo MP, Rodriguez ER, et al. The ISHLT working formulation for pathologic diagnosis of antibody-mediated rejection in heart transplantation: Evolution and current status (2005-2011). J Heart Lung Transplant 2011; 30: 601-11.
  1. Kucirka LM, Malesqewski JJ, Segey DL, Halushka MK. Survey of North American pathologist practices regarding antibody-mediated rejection in cardiac transplant biopsies. Cardiovascular Pathol 2011; 20: 132-8.
  1. Loupy A, Cazes A, Guillemain R, Amrein C, Hedjoudje A, Tible M, Pezzella V, Fabiani JN, Suberbielle C, Nochy D, Hill GS, Empana JP, Jouven X, Bruneval P, Duong Van Huyen JP. Very late heart transplant rejection is associated with microvascular injury, complement deposition and progression to cardiac allograft vasculopathy. Am J Transplant 2011; 11: 1478-87.
  1. Fishbein GA, Fishbein MC. Morphologic and immunohistochemical findings in antibody-mediated rejection of the cardiac allograft. Hum Immunol 2012; 73: 1213-7.
  1. Mengel M, Husain S, Hidalgo L, Sis B. Phenotypes of antibody-mediated rejection in organ transplants. TransplInt 2012; 25: 611-22.
  1. Leone O, Veinot JP, Angelini A, Baandrup UT, Basso C, Berry G, Bruneval P, Burke M, Butany J, Calabrese F, et al. 2011 Consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology. CardiovascPathol 2012; 21: 245-74.
  1. Mengel M, Sis B, Haas M, Colvin RB, Halloran PF, Racusen LC, Solez K, Cendales L, Demetris AJ, Drachenberg CB, Farver CF, Rodriguez ER, Wallace WD, Glotz D; Banff meeting report writing committee. Banff 2011 meeting report: new concept in antibody-mediated rejection. Am J Transplant 2012; 12: 563-70.
  1. Tible M, Loupy A, Vernerey D, Suberbielle C, Beuscart T, Cazes A, Guillemain R, Amrein C, Pezzella V, Fabiani JN, Nochy D, Hill G., Empana JP, Jouven X, Charron D, Bruneval P, Duong Van Huyen JP. Pathologic classification of antibody-mediated rejection correlates with donor-specific antibodies and endothelial cell activation. J Heart Lung Transplant 2013; 32: 769-76.
  1. Potena L, Bontadini A, Iannelli S, Fruet F, Leone O, Barberini F, Borgese L, Manfredini V, Masetti M, Magnani G, Fallani F, Grigioni F and Branzi A. Occurrence of fatal and nonfatal adverse outcomes after heart transplantation in patients with pretransplantnoncytotoxic HLA antibodies. J Transplant 2013 (Epub 2013 July 29).
  1. Berry GJ, Burke MM, Andersen C, Bruneval P, Fedrigo M, Fishbein MC, Goddard M, Hammond EH, Leone O, Marboe C, Miller D, Neil D, Rassl D, Revelo MP, Rice A, Rodriguez ER, Stewart S, Tan CD, Winters GL, West L, Mehra MR, Angelini A. The 2013 ISHLTWorking Formulation for the Standardization of Nomenclature in the Pathologic Diagnosis of Antibody-mediated Rejection in Heart Transplantation. J Heart Lung Transplant 2013 (accepted for publication).

Abstract presentations

  1. Burke M, Andersen CB, Ashworth M, et al. C4d methodolody and interpretation in diagnosis of cardiac antibody-mediated rejection: a European survey from the Association for European Cardiovascular Pathology (AECVP). J Heart Lung Transplant 2010; 29: S37-S38.
  1. Fedrigo M, Leone O, Burke M, Rice A, Torbenson M, Toquet C, Frigo AC, Guillemain R, Pattier S, Smith J, et al. Inflammatory cell burden and phenotype in endomyocardial biopsies from patients with antibody-mediated rejection (AMR) - An AECVP multicenter study. J Heart Lung Transplant 2013; 32 [4S]: S19.